Blockade of Beta-Catenin/ALDH1 Axis Toward Effective Suppression of High Metastatic Osteosarcoma: Preclinical Study of a Novel Wnt/Beta-Catenin Pathway Inhibitor Tegavivint

被引：0
|
作者：
Nomura, Motonari [1 ,2 ,3 ]
机构：
[1] Osaka Univ, Grad Sch Univ, Dept Pediat Surg, Osaka, Japan
[2] Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan
[3] Texas Childrens Hosp, Baylor Coll of Med, Houston, TX 77030 USA
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES7-3-2
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [41] MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway
    Li, Qifeng
    Shen, Ke
    Zhao, Yang
    Ma, Chenkai
    Liu, Jianwen
    Ma, Jie
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [42] MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway
    Qifeng Li
    Ke Shen
    Yang Zhao
    Chenkai Ma
    Jianwen Liu
    Jie Ma
    Journal of Translational Medicine, 11
  • [43] 2-Aminopyrimidine agonists of the Wnt beta-catenin cellular messaging system 1: Lead optimization studies toward the discovery of WAY-262611
    Lundquist, Joseph T.
    Gilbert, Adam M.
    Pelletier, Jeffrey C.
    Alon, Nipa
    Bex, Frederick J.
    Bhat, Bheem
    Bursavich, Matt
    Coleburn, Valerie
    Felix, Luciana
    Hauze, Diane
    Lam, Ho-Sun
    Lockhead, Susan
    Magolda, Ronald L.
    Matteo, Jeanne
    Mehlmann, John F.
    Murrills, Richard
    Wrobel, Jay
    Bodine, Peter V. N.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [44] Loss of expression of Wnt/Beta-catenin signaling pathway transcription factors LEF-1 and TCF-1 in a subset of peripheral T cell lymphomas
    Dorfman, DM
    Greisman, H
    Shahsafaei, A
    MODERN PATHOLOGY, 2003, 16 (01) : 230A - 231A
  • [45] Loss of expression of Wnt/beta-catenin signaling pathway transcription factors LEF-1 and TCF-1 in a subset of peripheral T cell lymphomas
    Dorfman, DM
    Greisman, H
    Shahsafaei, A
    LABORATORY INVESTIGATION, 2003, 83 (01) : 230A - 231A
  • [46] WNT-1 expression in basal cell carcinoma of head and neck.: An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin
    Lo Muzio, L
    Pannone, G
    Staibano, S
    Mignogna, MD
    Grieco, M
    Ramires, P
    Romito, AM
    De Rosa, G
    Piattelli, A
    ANTICANCER RESEARCH, 2002, 22 (2A) : 565 - 576
  • [47] Nanoyarn delivering Wnt/beta-catenin pathway inhibitor fabricated with the composite system of dynamic Liquid and co-axil electrospinning for reconstruction of urethral defect dog model
    Zhang, K.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 207 - 208
  • [48] Wnt4 is a novel promoter of VSMC proliferation and intimal thickening by the NFATc1 non-canonical and beta-catenin canonical pathways
    Tsaousi, Aikaterini
    Connolly, Georgia M.
    George, Sarah J.
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 358 - 358
  • [49] FUNCTIONAL INHIBITION OF IGF1R IN ADRENOCORTICAL TUMORS CELLS PROMOTES CELLULAR DEATH AND CHANGES GENE EXPRESSION OF WNT/BETA-CATENIN PATHWAY COMPONENTS
    Scrideli, C. A.
    Lira, R. C. P.
    Leal, L. F.
    Fedatto, P. F.
    Martinelli, C. E., Jr.
    Castro, M.
    Tucci, S., Jr.
    Neder, L.
    Ramalho, L. N. Z.
    Seidinger, M. L.
    Cardinalli, I.
    Mastellaro, M. J.
    Yunes, J. A.
    Brandalise, S. R.
    Tone, L. G.
    Antonini, S. R. R.
    Scrideli, C. A.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S226 - S226
  • [50] LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway
    Xiao, C.
    Wu, C. -H.
    Hu, H. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (13) : 2819 - 2824
12345